Tema Oncology ETF (CANC) Institutional Ownership $26.94 +0.03 (+0.11%) Closing price 04:00 PM EasternExtended Trading$26.81 -0.13 (-0.48%) As of 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Tema Oncology ETF (NASDAQ:CANC)Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$14.03MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$2.81M Get CANC Insider Trade Alerts Want to know when executives and insiders are buying or selling Tema Oncology ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CANC Institutional Buying and Selling by Quarter Tema Oncology ETF Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2025Jane Street Group LLC8,829$213K0.0%N/A0.326% 5/16/2025Banque Transatlantique SA1,750$39K0.0%N/A0.065% 2/10/2025Thrivent Financial for Lutherans517,837$13.16M0.0%+29.6%20.307% 11/15/2024Jane Street Group LLC44,311$1.26M0.0%-69.1%2.547% 11/7/2024Thrivent Financial for Lutherans399,509$11.35M0.0%+25.1%22.960% 8/13/2024Thrivent Financial for Lutherans319,376$8.62M0.0%N/A19.010% (Data available from 1/1/2016 forward) CANC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CANC shares? During the previous two years, the following institutional investors and hedge funds held shares of Tema Oncology ETF shares: Thrivent Financial for Lutherans ($13.16M), and Jane Street Group LLC ($213K), Banque Transatlantique SA ($39K).Learn more on Tema Oncology ETF's institutional investors. Which institutional investors have been buying Tema Oncology ETF's stock? The following institutional investors have purchased Tema Oncology ETF's stock in the last 24 months: Thrivent Financial for Lutherans ($517.84K), Jane Street Group LLC ($8.83K), and Banque Transatlantique SA ($1.75K). How much institutional buying is happening at Tema Oncology ETF? Institutional investors have bought a total of 528,416 shares in the last 24 months. This purchase volume represents approximately $14.03M in transactions. Which of Tema Oncology ETF's major shareholders have been selling company stock? The following institutional investors have sold Tema Oncology ETF stock in the last 24 months: Jane Street Group LLC ($98.88K). How much institutional selling is happening at Tema Oncology ETF? Institutional investors have sold a total of 98,880 shares in the last 24 months. This volume of shares sold represents approximately $2.81M in transactions. Related Companies EBIZ Major Shareholders VPN Major Shareholders SPRX Major Shareholders XAIX Major Shareholders AGNG Major Shareholders SETM Major Shareholders ZAP Major Shareholders MAGX Major Shareholders FDCF Major Shareholders FMED Major Shareholders This page (NASDAQ:CANC) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Oncology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CANC Stock Alerts